FDA-Inspected Site

Apnar Pharma LLP

4 FDA inspections are on record for Apnar Pharma LLP in East Windsor, United States.

483· Form 483 issued

East Windsor, United States · Last updated August 15, 2026

Overview

  • 4 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-05-22.

At a glance

Inspections

4

Form 483s

3

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
18 May 2026 – 22 May 2026Human Drugs483View 483 →
11 Aug 2022 – 1 Sep 2022Human DrugsClean
4 May 2021 – 14 May 2021Human Drugs483View 483 →
30 Jun 2015 – 10 Jul 2015Foods & Cosmetics483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

22 May 2026
21 CFR 211.180(e)

Records reviewed annually

Cited by Ankur C Patel

22 May 2026
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Ankur C Patel

14 May 2021
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Monika Borkowska

14 May 2021
21 CFR 211.67(b)

Written procedures fail to include

Cited by Monika Borkowska

14 May 2021
21 CFR 211.80(a)

Procedures To Be in Writing

Cited by Monika Borkowska

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 111.16Cited across public-safe Form 483 observations2x
21 CFR 211.22(d)Cited across public-safe Form 483 observations2x
21 CFR 111.103Cited across public-safe Form 483 observations1x
21 CFR 111.255(b)Cited across public-safe Form 483 observations1x
21 CFR 111.353Cited across public-safe Form 483 observations1x
21 CFR 111.553Cited across public-safe Form 483 observations1x
21 CFR 111.73Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(2)(ii)(A)Cited across public-safe Form 483 observations1x
21 CFR 111.83(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Apnar Pharma LLP's 3 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat